Castlight Health (CSLT) Tops Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Wall St futures pause after AI rally, focus on Mideast tensions
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Castlight Health's (CSLT) Slight Beat and Mixed Guide Keeps Leerink Partners on the Sidelines - PT to $3.50
February 18, 2016 8:26 AM ESTLeerink Partners reiterated a Market Perform rating on Castlight Health Inc. (NYSE: CSLT), and cut the price target to $3.50 (from $5.00), following the company's 4Q earnings report. Revenue of $21.3m was slightly above guidance of $20.7-21m and consensus at $20.9m. Non-GAAP EPS came in at... More
